从现场预康复与康复项目到移动应用:机器人辅助根治性前列腺切除术5年经验、COVID-19疫情及与全国数据的比较
本文报告了机器人辅助根治性前列腺切除术预康复项目5年经验,期间当日出院率从0%升至26.4%,住院时间从3天降至0.9天,费用降低63%。尽管有这些优势,项目维持和推广受限于缺乏激励支持和人力资源,因此开发了两款免费移动应用。
要点
- 预康复项目使当日出院率从0%升至26.4%,住院时间从3天降至0.9天。
- 项目期间费用降低63%,术后30天内院外天数改善。
- 项目维持和推广受限于缺乏激励支持和人力资源,因此开发了免费移动应用。
核心结论
- 预康复项目可优化机器人辅助根治性前列腺切除术后患者结局,但维持和推广因缺乏激励支持和人力资源而具有挑战性,因此开发了免费移动应用。
研究设计与样本
- 本文报告了本中心5年现场预康复项目的经验及其对患者和医院结局的影响,并与同期全国数据进行比较。
主要发现
- 项目期间当日出院率从0%升至26.4%,住院时间从3天降至0.9天,费用降低63%,术后30天内院外天数改善。
- 上述改善与同期全国数据比较亦可见。
临床怎么用
- 原文未据此给出推荐。
局限性
- 项目维持和推广因缺乏激励支持和人力资源而具有挑战性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prehabilitation programs play a key role in optimizing patient experiences and outcomes after surgery. However, there are few data on robot-assisted radical prostatectomy, and prehabilitation programs may be challenging to launch and maintain over time for every patient. Here we report our 5-yr experience of an on-site prehabilitation program and its impact on patient and hospital outcomes. During the study period, we observed continuous improvements in the same-day discharge rate (from 0% to 26.4%), hospital stay (from 3 to 0.9. d), costs (-63%), days out of hospital within 30 d after surgery in our center, and in comparison to contemporary nationwide data. However, despite these advantages, maintenance and diffusion of this program could be challenging owing to the absence of incentive support and lack of human resources. This led us to develop two free-access mobile apps, available on the app stores for both patients and surgeons, that include checklists, remote monitoring, and multiple educational materials aimed at simplifying the widespread use of optimized perioperative pathways. PATIENT SUMMARY: We found that a prehabilitation program before surgery can help in optimizing patient outcomes after robot-assisted removal of the prostate. We translated this program into a mobile app available for every patient.
引用
- Ploussard G, Kesch C, Calleris G, et al. From an On-site Program to a Mobile App for Prehabilitation and Rehabilitation for Robotic Radical Prostatectomy: Lessons Learned from 5 Years of Experience, the COVID-19 Outbreak, and Comparison with Nationwide Data. Eur Urol Oncol. 2023. PMID: 37865569. doi:10.1016/j.euo.2023.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。